4-hydroxycyclophosphamide has been researched along with Di Guglielmo Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ascensao, JL; Silva, MR; Vaz, F | 1 |
1 other study(ies) available for 4-hydroxycyclophosphamide and Di Guglielmo Disease
| Article | Year |
|---|---|
Enhanced lymphokine-activated killer cell activity by an immunomodulator, Roquinimex.
Topics: Adjuvants, Immunologic; Bone Marrow; Bone Marrow Cells; Bone Marrow Purging; Cell Count; Cell Division; Cells, Cultured; Cyclophosphamide; Hematopoietic Stem Cells; Humans; Hydroxyquinolines; Killer Cells, Lymphokine-Activated; Killer Cells, Natural; Leukemia, Erythroblastic, Acute; Leukocytes, Mononuclear; Lymphocyte Activation; Phenotype; Stimulation, Chemical; Tumor Cells, Cultured | 1995 |